Scarica l'app Stockscreener
18.33
3.21%
0.57
Dopo l'orario di chiusura:
18.33
Precedente Chiudi:
$17.76
Aprire:
$18
Volume 24 ore:
438.48K
Relative Volume:
1.29
Capitalizzazione di mercato:
$689.96M
Reddito:
$89.06M
Utile/perdita netta:
$-53.41M
Rapporto P/E:
-12.54
EPS:
-1.4612
Flusso di cassa netto:
$-42.48M
1 W Prestazione:
-3.12%
1M Prestazione:
-1.82%
6M Prestazione:
+59.53%
1 anno Prestazione:
-4.58%
Intervallo 1D:
$17.67
$18.38
Intervallo di 1 settimana:
$17.50
$20.16
Portata 52W:
$10.01
$24.33
Ceribell Inc Stock (CBLL) Company Profile
Nome
Ceribell Inc
Settore
Industria
Telefono
(800) 436-0826
Indirizzo
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
18.33 | 668.51M | 89.06M | -53.41M | -42.48M | -1.4612 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-21 | Iniziato | Raymond James | Strong Buy |
| 2025-06-24 | Iniziato | BTIG Research | Buy |
| 2025-04-04 | Iniziato | Ladenburg Thalmann | Buy |
| 2024-11-05 | Iniziato | BofA Securities | Buy |
| 2024-11-05 | Iniziato | Canaccord Genuity | Buy |
| 2024-11-05 | Iniziato | JP Morgan | Overweight |
| 2024-11-05 | Iniziato | TD Cowen | Buy |
| 2024-11-05 | Iniziato | William Blair | Outperform |
Mostra tutto
Ceribell Inc Borsa (CBLL) Ultime notizie
Short Interest in CeriBell, Inc. (NASDAQ:CBLL) Declines By 13.8% - MarketBeat
CeriBell, Inc. (NASDAQ:CBLL) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Ceribell (CBLL) CEO exercises stock options, now holds 766,792 shares - Stock Titan
Ceribell, Inc. honors Alex Purcell with Citizens Award for leadership in training initiatives - Traders Union
Buyback Watch: Is CeriBell Inc forming a breakout pattern2026 Trade Ideas & Real-Time Market Sentiment Reports - baoquankhu1.vn
ETF Watch: What are the risks of holding CeriBell Inc2026 Volume Leaders & Safe Capital Growth Stock Tips - baoquankhu1.vn
Ceribell, Inc. (CBLL) reports Q4 loss, beats revenue estimates - MSN
CeriBell, Inc. (NASDAQ:CBLL) Short Interest Update - MarketBeat
CBLL PE Ratio & Valuation, Is CBLL Overvalued - Intellectia AI
Suma receives Ceribell, Inc. accolade for breakthrough neonatal care innovation - Traders Union
Ceribell’s Woo sells $202k in shares - Investing.com Nigeria
Foehr David, senior VP at Ceribell, sells $81k in CBLL stock - Investing.com Nigeria
CeriBell Conference: CFO Highlights 36% Revenue Growth, Expands EEG Platform to Pediatrics and Delirium - Yahoo Finance
CeriBell Highlights 2026 Growth Plan at TD Cowen: 25%-29% Guide, VA Ramp, Delirium Pilot - Yahoo Finance
CBLL wins FDA breakthrough status for AI-based LVO stroke detection - MSN
Robertson sells Ceribell (CBLL) shares worth $14,720 By Investing.com - Investing.com India
CeriBell (NASDAQ:CBLL) CEO Sells $680,550.00 in Stock - MarketBeat
CeriBell (NASDAQ:CBLL) Director Rebecca Robertson Sells 827 Shares - MarketBeat
David Foehr Sells 4,560 Shares of CeriBell (NASDAQ:CBLL) Stock - MarketBeat
Robertson sells Ceribell (CBLL) shares worth $14,720 - Investing.com Nigeria
Ceribell CEO Chao sells $680k in CBLL stock By Investing.com - Investing.com Canada
Ceribell CEO Chao sells $680k in CBLL stock - Investing.com India
Ceribell Insider Sold Shares Worth $680,564, According to a Recent SEC Filing - marketscreener.com
Director at Ceribell (CBLL) sells 827 shares via Rule 10b5-1 plan - Stock Titan
Ceribell Earnings Call Highlights Strong Growth, Rising Costs - The Globe and Mail
Ceribell’s Woo sells $202k in shares By Investing.com - Investing.com Australia
CeriBell (NASDAQ:CBLL) CTO Sells $147,587.75 in Stock - MarketBeat
CBLL (NASDAQ: CBLL) affiliate Xingjuan Chao sells multiple blocks totaling 145,084 shares - Stock Titan
CBLL (NASDAQ: CBLL) Rule 144 notice; affiliate to sell 4,560 shares - Stock Titan
CeriBell, Inc. (NASDAQ:CBLL) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord - Insider Monkey
CBLL SEC FilingsCeriBell, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
CeriBell, Inc. (CBLL) Stock Analysis: Exploring a 43% Potential Upside in the Innovative Medical Devices Sector - DirectorsTalk Interviews
CBLL Should I Buy - Intellectia AI
Analysts Offer Insights on Healthcare Companies: Ceribell, Inc. (CBLL) and Option Care Health (OPCH) - The Globe and Mail
Earnings Call Summary | Ceribell(CBLL.US) Q4 2025 Earnings Conference - 富途牛牛
CeriBell (CBLL) Revenue Growth To US$24.8m Tests Premium Valuation Narrative - simplywall.st
Top Ceribell Executives Quietly Unload Shares in Coordinated Insider Move - TipRanks
Insider Selling: CeriBell (NASDAQ:CBLL) VP Sells 569 Shares of Stock - MarketBeat
Insider Selling: CeriBell (NASDAQ:CBLL) CTO Sells 705 Shares of Stock - MarketBeat
CeriBell (NASDAQ:CBLL) VP David Foehr Sells 781 Shares - MarketBeat
Insider Selling: CeriBell (NASDAQ:CBLL) CFO Sells 808 Shares of Stock - MarketBeat
[Form 4] Ceribell, Inc. Insider Trading Activity - Stock Titan
Ceribell: Strong Q4 Beat, Multi-Year Growth Drivers, and Clear Path to Profitability Support Buy Rating - TipRanks
CeriBell (NASDAQ:CBLL) Shares Gap DownTime to Sell? - MarketBeat
Ceribell Inc. debuts AI-enabled neonatal EEG at NEO Pediatrix Conference - Traders Union
CeriBell revenue up 34% to USD 24.8M in Q4 2025 - Medical Buyer
CeriBell Q4 Revenue Rises 34%; Projects Revenue Growth Of 25%-29% For FY'26 - Nasdaq
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results - The Globe and Mail
CeriBell (CBLL) Q4 2025 Earnings Call Transcript - The Globe and Mail
Ceribell: Strong Top-Line Outperformance and Expanding Growth Vectors Underpin Buy Rating - TipRanks
Ceribell Inc Azioni (CBLL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ceribell Inc Azioni (CBLL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Foehr David | Senior VP, Finance and PAO |
Mar 03 '26 |
Option Exercise |
4.70 |
4,560 |
21,432 |
20,953 |
| Foehr David | Senior VP, Finance and PAO |
Mar 03 '26 |
Sale |
17.80 |
4,560 |
81,168 |
17,550 |
| ROBERTSON REBECCA B | Director |
Mar 03 '26 |
Sale |
17.80 |
827 |
14,721 |
18,749 |
| Chao Xingjuan | President and CEO |
Mar 03 '26 |
Option Exercise |
4.70 |
25,000 |
117,500 |
734,718 |
| Chao Xingjuan | President and CEO |
Mar 03 '26 |
Sale |
17.45 |
39,000 |
680,564 |
711,164 |
| Woo Raymond | Chief Technology Officer |
Mar 02 '26 |
Option Exercise |
4.37 |
11,112 |
48,605 |
173,527 |
| Woo Raymond | Chief Technology Officer |
Mar 02 '26 |
Sale |
18.25 |
8,087 |
147,602 |
166,912 |
2.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):